GH Research PLC (GHRS)
NASDAQ: GHRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GHRS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.45B
- EPS (TTM)
- -$0.99
- Dividend yield
- None
- 52-week range
- 12.04 – 31.44
- Day range
- 21.00 – 22.17
- Volume / Avg
- 304.64K / 296.78K
- Beta
- —
- Shares outstanding
- 68.64M
- Next earnings
- Nov 5, 2026
52-week range
GHRS stock today
GH Research (GHRS) closed at $21.06 on Oct 7, down 2.14% (-$0.46), versus the S&P 500's 0.22% decline. At this level, GHRS sits in the middle of its 52-week range of $12.04 to $31.44: 33.0% below the high, set on Aug 7, 2026 and 74.9% above the low. GHRS is up 65.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 60.9%.
GH Research has posted a net loss over the last twelve months (EPS of -$0.99), so its P/E ratio is not meaningful. GH Research's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About GH Research
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Dublin 2
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.27
GH Research peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRSAKorsana Biosciences Inc. | 31.65 | -0.38% | $1.44B | vs GHRS |
| RAREUltragenyx Pharmaceutical Inc. | 14.89 | +2.97% | $1.47B | vs GHRS |
| RAPPRapport Therapeutics Inc. | 30.86 | -0.93% | $1.48B | vs GHRS |
| TYRATyra Biosciences Inc. | 20.39 | +0.74% | $1.40B | vs GHRS |
| AAPGAscentage Pharma Group International American Depository Shares | 14.94 | -7.15% | $1.40B | vs GHRS |
| NKTRNektar Therapeutics | 40.26 | +0.88% | $1.37B | vs GHRS |
| SNDXSyndax Pharmaceuticals Inc. | 17.03 | -1.96% | $1.52B | vs GHRS |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs GHRS |
Indexes, lists and sector
GH Research stock FAQ
What is GH Research's stock price today?
GHRS last traded at $21.06 as of Oct 7, 4:00 PM EDT, down 2.14% on the day. Prices are delayed at least 15 minutes.
When is GH Research's next earnings date?
GH Research is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.27.
What is the GHRS 52-week high?
The 52-week high for GHRS is $31.44 and the 52-week low is $12.04. The stock is currently 33.0% below its high.